Ketamine for Treatment-Resistant Depression: Neurobiology and Applications

Ketamine for Treatment-Resistant Depression: Neurobiology and Applications

Vazquez, Gustavo H.
Zarate Jr., Carlos A.
Brietzke, Elisa

90,43 €(IVA inc.)

After the first studies exploring the potential of intravenous ketamine in the treatment of treatment-resistant depression, ketamine is becoming a wide spread alternative for a large number of patients. Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers about this medication, its mechanisms of actions, the eligibility of patients for the treatment and the preparation and implementation of ketamine clinics. Provides efficacy research on ketamine as treatment for depressionIdentifies best practices for clinical use, both long term and acuteDiscusses molecular mechanisms and neurobiology of action INDICE: 1. History2. Pharmacology3. Translational Approach4. TRD5. Suicide in Mood Disorders6. Effectiveness in MADs7. How to implement a ketamine clinic8. New developments of rapid agents9. Consumers view10. Closing remarks

  • ISBN: 978-0-12-821033-8
  • Editorial: Academic Press
  • Encuadernacion: Rústica
  • Páginas: 150
  • Fecha Publicación: 01/10/2020
  • Nº Volúmenes: 1
  • Idioma: Inglés